{
  "created_at": "2020-12-08T15:36:13.000Z",
  "updated_at": "2021-01-06T08:25:13.110Z",
  "id": "93baf63e-4e54-4edc-8111-dac607b3cbfb",
  "labels": "current-affairs,2020-12-09",
  "question": "Which pharma company has become the first firm to ask for 'Emergency use authorisation' from India?",
  "option1": "Astra Zeneca",
  "option2": "Pfizer",
  "option3": "Ranbaxy",
  "option4": "Cipla",
  "option5": "",
  "answer": "Pfizer",
  "explanation": "Pfizer has approached the Drugs Controller General of India (DCGI) seeking for emergency use authorisation (EUA) for its COVID 19 vaccine in India. <br />The company has obtained the emergency use authorisation from United Kingdom and Bahrain recently. The company has asked permission to DCGI for distribution of its COVID vaccine in India and waiver of clinical trials."
}